Does RISPERIDONE Cause Interstitial lung disease? 20 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Interstitial lung disease have been filed in association with RISPERIDONE (Risperidone). This represents 0.0% of all adverse event reports for RISPERIDONE.
20
Reports of Interstitial lung disease with RISPERIDONE
0.0%
of all RISPERIDONE reports
1
Deaths
8
Hospitalizations
How Dangerous Is Interstitial lung disease From RISPERIDONE?
Of the 20 reports, 1 (5.0%) resulted in death, 8 (40.0%) required hospitalization, and 11 (55.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does RISPERIDONE Cause?
Gynaecomastia (24,453)
Off label use (10,376)
Abnormal weight gain (9,418)
Weight increased (6,885)
Emotional disorder (5,809)
Product use in unapproved indication (5,551)
Drug ineffective (5,232)
Injury (4,447)
Hyperprolactinaemia (4,124)
Galactorrhoea (3,513)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RISPERIDONE Alternatives Have Lower Interstitial lung disease Risk?
RISPERIDONE vs RITALIN
RISPERIDONE vs RITLECITINIB
RISPERIDONE vs RITODRINE
RISPERIDONE vs RITONAVIR
RISPERIDONE vs RITUXAN